Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains one of the leading
infectious causes of death globally, with drug resistance presenting a significant challenge …

Metformin is the preferred oral medication for patients with type 2 diabetes mellitus, and this
blood glucose-lowering and insulin-sensitizing drug has immunomodulatory effects that …

Introduction The incidence and prevalence of infections with non-tuberculous mycobacteria
such as Mycobacterium avium (Mav) are increasing. Prolonged drug regimens, inherent …

Resistant M. tuberculosis strains threaten pulmonary tuberculosis (P-TB) control since they
limit drug options. Drug repositioning and new development strategies are urgently required …

Аннотация Метформин, известный медицинскому сообществу как препарат выбора
при сахарном диабете 2-го типа, относится к группе бигуанидов и давно используется в …

Hepatitis C virus is an important global cause of hepatitis and subsequently cirrhosis and
hepatocellular carcinoma. These infections may also cause extrahepatic manifestations …

Tuberculosis (TB) continues to be a major global health issue, causing millions of deaths
annually [1]. The increasing prevalence of diabetes mellitus (DM) worldwide complicates the …

Metformin, known in the medical community as the drug of first choice for type 2 diabetes
mellitus, belongs to the group of biguanides and has proven to be an effective treatment in …

Метформин, известный медицинскому сообществу как препарат выбора при сахарном
диабете 2-го типа, относится к группе бигуанидов и давно используется в клинической …

Background: Diabetes mellitus triples the risk of infection, leading to poor clinical outcomes.
Hyperglycemia suppresses immune responses, affecting TB and diabetes patients …